These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties. Morlock M; Kissel T; Li YX; Koll H; Winter G J Control Release; 1998 Dec; 56(1-3):105-15. PubMed ID: 9801434 [TBL] [Abstract][Full Text] [Related]
25. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres. Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228 [TBL] [Abstract][Full Text] [Related]
26. Formulation, characterization, and evaluation of ketorolac tromethamine-loaded biodegradable microspheres. Sinha VR; Trehan A Drug Deliv; 2005; 12(3):133-9. PubMed ID: 16025842 [TBL] [Abstract][Full Text] [Related]
27. Biocompatibility of poly (DL-lactide-co-glycolide) microspheres implanted into the brain. Emerich DF; Tracy MA; Ward KL; Figueiredo M; Qian R; Henschel C; Bartus RT Cell Transplant; 1999; 8(1):47-58. PubMed ID: 10338275 [TBL] [Abstract][Full Text] [Related]
28. Bioadhesive fluorescent microspheres as visible carriers for local delivery of drugs. II: Uptake of insulin-loaded PCEFB/PLGA microspheres by the gastrointestinal tract. Li Y; Jiang HL; Jin JF; Zhu KJ Drug Deliv; 2004; 11(6):335-40. PubMed ID: 15736827 [TBL] [Abstract][Full Text] [Related]
29. Delivering neuroactive molecules from biodegradable microspheres for application in central nervous system disorders. Cao X; Schoichet MS Biomaterials; 1999 Feb; 20(4):329-39. PubMed ID: 10048405 [TBL] [Abstract][Full Text] [Related]
30. Controlled delivery of the anti-VEGF aptamer EYE001 with poly(lactic-co-glycolic)acid microspheres. Carrasquillo KG; Ricker JA; Rigas IK; Miller JW; Gragoudas ES; Adamis AP Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):290-9. PubMed ID: 12506087 [TBL] [Abstract][Full Text] [Related]
31. The encapsulation of ribozymes in biodegradable polymeric matrices. Jackson JK; Liang LS; Hunter WL; Reynolds M; Sandberg JA; Springate C; Burt HM Int J Pharm; 2002 Aug; 243(1-2):43-55. PubMed ID: 12176294 [TBL] [Abstract][Full Text] [Related]
32. Tetracycline-HCl-loaded poly(DL-lactide-co-glycolide) microspheres prepared by a spray drying technique: influence of gamma-irradiation on radical formation and polymer degradation. Bittner B; Mäder K; Kroll C; Borchert HH; Kissel T J Control Release; 1999 May; 59(1):23-32. PubMed ID: 10210719 [TBL] [Abstract][Full Text] [Related]
33. pH and osmotic pressure inside biodegradable microspheres during erosion. Brunner A; Mäder K; Göpferich A Pharm Res; 1999 Jun; 16(6):847-53. PubMed ID: 10397604 [TBL] [Abstract][Full Text] [Related]
34. Artificial polymeric cells for targeted drug delivery. Eniola AO; Hammer DA J Control Release; 2003 Feb; 87(1-3):15-22. PubMed ID: 12618019 [TBL] [Abstract][Full Text] [Related]
35. Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes. Eniola AO; Rodgers SD; Hammer DA Biomaterials; 2002 May; 23(10):2167-77. PubMed ID: 11962658 [TBL] [Abstract][Full Text] [Related]
36. Kinetics of a model nucleoside (guanosine) release from biodegradable poly(DL-lactide-co-glycolide) microspheres: a delivery system for long-term intraocular delivery. Chowdhury DK; Mitra AK Pharm Dev Technol; 2000; 5(2):279-85. PubMed ID: 10810757 [TBL] [Abstract][Full Text] [Related]
37. Determination of protein loading in biodegradable polymer microspheres containing tetanus toxoid. Gupta RK; Chang AC; Griffin P; Rivera R; Guo YY; Siber GR Vaccine; 1997; 15(6-7):672-8. PubMed ID: 9178469 [TBL] [Abstract][Full Text] [Related]
38. Clearance of microsphere-entrapped 5-fluorouracil and cytosine arabinoside from the vitreous of primates. Peyman GA; Conway M; Khoobehi B; Soike K Int Ophthalmol; 1992 Mar; 16(2):109-13. PubMed ID: 1587693 [TBL] [Abstract][Full Text] [Related]
40. Development of a Sustainable Release System for a Ranibizumab Biosimilar Using Poly(lactic-co-glycolic acid) Biodegradable Polymer-Based Microparticles as a Platform. Tanetsugu Y; Tagami T; Terukina T; Ogawa T; Ohta M; Ozeki T Biol Pharm Bull; 2017; 40(2):145-150. PubMed ID: 28154252 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]